1. Home
  2. KTOS vs GH Comparison

KTOS vs GH Comparison

Compare KTOS & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kratos Defense & Security Solutions Inc.

KTOS

Kratos Defense & Security Solutions Inc.

HOLD

Current Price

$83.58

Market Cap

13.4B

Sector

Industrials

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$84.98

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTOS
GH
Founded
1994
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4B
13.3B
IPO Year
1999
2018

Fundamental Metrics

Financial Performance
Metric
KTOS
GH
Price
$83.58
$84.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
20
Target Price
$97.44
$117.80
AVG Volume (30 Days)
4.0M
1.7M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
18.18
6.74
EPS
0.13
N/A
Revenue
$751,900,000.00
$982,021,000.00
Revenue This Year
$24.96
$33.40
Revenue Next Year
$23.89
$28.55
P/E Ratio
$714.62
N/A
Revenue Growth
12.44
32.88
52 Week Low
$27.51
$36.36
52 Week High
$134.00
$120.74

Technical Indicators

Market Signals
Indicator
KTOS
GH
Relative Strength Index (RSI) 41.49 34.88
Support Level $82.27 $82.26
Resistance Level $95.85 $103.16
Average True Range (ATR) 5.67 3.94
MACD 0.25 0.07
Stochastic Oscillator 12.87 19.92

Price Performance

Historical Comparison
KTOS
GH

About KTOS Kratos Defense & Security Solutions Inc.

Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: